Janney Reiterates Buy, $20 Target On Amicus Therapeutics Notes Co's 'Analyst Day Should Boost Investor Confidence'; Notes 'Financial discussions in the opening session a little unusual but not surprising'

Do you like seeing these details as to why an analyst recommended a stock? What could we do to make this product better? Let us know by emailing newsdesk@benzinga.com

Benzinga · 11/11/2019 19:11